Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsHydroxychloroquine (hcq)

    Hydroxychloroquine (hcq)

    Jump to

    • Coronavirus pandemic | Healthcare workers need PPE to prevent COVID-19 infection, not HCQ: Study

      The study titled ‘Prevalence of flu-like symptoms and COVID-19 in healthcare workers from India' found that “HCQ prophylaxis played no role in the prevention of this (coronavirus) infection”.

    • Coronavirus pandemic | India will continue HCQ treatment for mild COVID-19 cases

      Health ministry officials, Indian Council of Medical Research (ICMR) experts, and the Drug Controller General of India have collectively reviewed the novel coronavirus clinical management protocol and decided to limit HCQ use to moderate patients.

    • WHO resumes HCQ coronavirus trials

      The WHO has previously recommended against using hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.

    • Coronavirus pandemic | HCQ doses reduced COVID-19 risk among healthcare workers: ICMR study

      The ICMR study suggested that taking HCQ in four or more “maintenance doses” resulted in a considerable decline in the chances of healthcare workers getting infected by the novel coronavirus.

    • Coronavirus pandemic: From plasma therapy to Favipiravir, here's a list of treatments and antidotes for COVID-19 so far

      The science and technology ministry has reportedly earmarked 42 existing drugs, narrowed down from a list of at least 2,100 approved drugs, for repurposing.

    • FDI warns against consuming chloroquine, HCQ to treat COVID-19 after deaths, 'serious' poisoning reported

      The agency also warned physicians against prescribing the drugs to treat the coronavirus outside of a hospital.

    • Explained | Why is Hydroxychloroquine under global spotlight?

      Moneycontrol's Shraddha Sharma explains what Hydroxychloroquine or HCQ is and why its demand is on a rise

    • Coronavirus pandemic opens up a huge opportunity for Indian pharma

      Local drug companies should address some of the longer term issues concerning the industry such as quality and good manufacturing practices

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347